You just read:

Global Diabetes & Obesity Drug Development Pipeline Review 2016: Cluster is Dominated by Therapeutics Indicated for T1DM and T2DM - Research and Markets

News provided by

Research and Markets

28 Nov, 2016, 14:10 ET